139 related articles for article (PubMed ID: 17297030)
1. Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso.
Diallo DA; Sutherland C; Nebié I; Konaté AT; Ord R; Pota H; Roper C; Ilboudo-Sanogo E; Greenwood BM; Cousens SN
Am J Trop Med Hyg; 2007 Feb; 76(2):237-44. PubMed ID: 17297030
[TBL] [Abstract][Full Text] [Related]
2. Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected children.
Diallo DA; Sutherland C; Nebie I; Konate AT; Ord R; Ilboudo-Sanogo E; Greenwood BM; Cousens SN
J Infect Dis; 2007 Jul; 196(1):138-44. PubMed ID: 17538894
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Zakeri S; Afsharpad M; Raeisi A; Djadid ND
Malar J; 2007 Nov; 6():148. PubMed ID: 17999755
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
Zhong D; Afrane Y; Githeko A; Cui L; Menge DM; Yan G
BMC Infect Dis; 2008 Jul; 8():105. PubMed ID: 18671871
[TBL] [Abstract][Full Text] [Related]
7. Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya.
Shah M; Kariuki S; Vanden Eng J; Blackstock AJ; Garner K; Gatei W; Gimnig JE; Lindblade K; Terlouw D; ter Kuile F; Hawley WA; Phillips-Howard P; Nahlen B; Walker E; Hamel MJ; Slutsker L; Shi YP
PLoS One; 2011; 6(11):e26746. PubMed ID: 22096496
[TBL] [Abstract][Full Text] [Related]
8. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.
Checchi F; Durand R; Balkan S; Vonhm BT; Kollie JZ; Biberson P; Baron E; Le Bras J; Guthmann JP
Trans R Soc Trop Med Hyg; 2002; 96(6):664-9. PubMed ID: 12625147
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
10. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S
Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.
Mohapatra PK; Sarma DK; Prakash A; Bora K; Ahmed MA; Sarma B; Goswami BK; Bhattacharyya DR; Mahanta J
PLoS One; 2014; 9(9):e105562. PubMed ID: 25184337
[TBL] [Abstract][Full Text] [Related]
12. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
13. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine resistance before and after its withdrawal in Kenya.
Mwai L; Ochong E; Abdirahman A; Kiara SM; Ward S; Kokwaro G; Sasi P; Marsh K; Borrmann S; Mackinnon M; Nzila A
Malar J; 2009 May; 8():106. PubMed ID: 19450282
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000.
Tinto H; Zoungrana EB; Coulibaly SO; Ouedraogo JB; Traoré M; Guiguemde TR; Van Marck E; D'Alessandro U
Trop Med Int Health; 2002 Nov; 7(11):925-30. PubMed ID: 12390597
[TBL] [Abstract][Full Text] [Related]
20. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Nkhoma S; Molyneux M; Ward S
Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
